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a  b  s  t  r  a  c  t
Disruption  of  Ca2+ homeostasis  can lead  to  severe  damage  of  the pancreas,  resulting  in  premature  acti-
vation  of digestive  enzymes,  vacuolisation  and  necrotic  cell  death,  features  typical  of  acute  pancreatitis
(AP).  Therefore  a ﬁne  balance  between  Ca2+ release  from  internal  stores,  Ca2+ entry  and  extrusion  mech-
anisms  is  necessary  to  avoid  injury.  Precipitants  of  AP  induce  Ca2+ overload  of  the  pancreatic  acinar  cell
that causes  mitochondrial  dysfunction,  via  formation  of the  mitochondrial  permeability  transition  pore
(MPTP),  loss  of  ATP  production  and  consequent  necrosis.  Oxidative  stress  has  been  shown  to  occur  in  the
development  of  AP  and  may  modify  Ca2+ signalling  events  in  the  acinar  cell.  However,  the  precise  patho-
physiological  involvement  is currently  unclear  and  antioxidant  therapy  in the  clinic  has  largely  proved
ineffective.  Possible  reasons  for  this are  discussed,  including  evidence  that ROS generation  may  deter-
mine  cell death  patterns.  In contrast,  recent  evidence  has  indicated  the  potential  for AP  therapy  via  the
2+ntioxidants
rai
tore-operated calcium entry
PTP
itochondrial dysfunction
poptosis
prevention  of Ca -dependent  mitochondrial  damage.  Multiple  approaches  are  indicated  from  preclinical
ﬁndings;  1) inhibition  of  Ca2+ release  by  IP3R blockade,  2) inhibition  of Ca2+ entry  through  Orai1  blockade
and  3)  prevention  of  MPTP  formation.  Clinical  trials  of  drugs  which  prevent  mitochondrial  dysfunction
induced  by  Ca2+ overload  of  pancreatic  acinar  cells  are  imminent  and  may  provide  patient  beneﬁt  for  a
disease  that  currently  lacks  speciﬁc  therapy.
©  2016  The  Author(s).  Published  by  Elsevier  Ltd. This  is an open  access  article  under  the  CC  BY-NC-NDecrosis
license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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. Introduction: acute pancreatitis necessary for the breakdown of food. Homeostasis of the func-The exocrine pancreas is a highly specialised secretory organ
apable of synthesising, storing and releasing large quanti-
ies of digestive enzyme precursors into the small intestine,
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.0/).tional unit, the acinar cell, is therefore paramount for the smooth
running of physiological processes; disruption can lead to severe
damage of the pancreas, resulting in premature activation of zymo-
gens, vacuolisation and necrotic cell death, features typical of
acute pancreatitis (AP). This severe inﬂammatory disease, which
currently affects approximately 50 per 100,000 individuals per
year, is triggered predominantly by alcohol excess and gallstones,
e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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Fig. 1. Detection of ROS in primary human and mouse pancreatic acinar cells using confocal microscopy. A) Typical images and graphs showing Ca2+-dependent rises of
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tOS  induced by the bile acid taurolithocholic acid sulphate (TLCS), measured with 
cetylcysteine (NAC) [7], B) Co-localisation studies using MitoSox and Mitotracke
LCS-induced ROS increases measured with a novel lipophilic probe, RB-C18, recen
lthough diverse precipitants are recognised potentially suggesting
 common mechanism [1]. Severe cases of AP involve a systemic
nﬂammatory response syndrome (SIRS) that may  result in multi-
le organ damage and death of the patient. A prominent feature of
he development of AP is a disruption of calcium signalling within
he acinar cell [2–4]; overload of cytosolic calcium ([Ca2+]c) leadsCFDA in human and murine acinar cells, that were inhibited by the antioxidant N-
ated that bile acid- induced ROS generation occurred in the mitochondria [7], C)
veloped for detecting near-membrane responses [16].
to signiﬁcant damage of the mitochondria, critically affecting their
ability to produce ATP, thereby promoting cell death [5]. Impor-
tantly, the extent of pancreatic necrosis, which may develop in
patients within days of symptom onset, is a major determinant of
disease progression; the presence of necrosis dramatically raises
the mortality rate in AP [1,6]. Sustained rises of [Ca2+]c have been
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hown to cause maintained elevations of reactive oxygen species
ROS) within the acinar cell that promote cell death [7]. However,
he precise involvement of oxidative stress in the development of
P is still unclear [8], mirrored by a disappointing translation of
ntioxidant treatment to the clinic to-date [9]. This review will
ocus on current evidence relating to the actions of ROS and Ca2+
n determining cell death in the exocrine pancreas, with particular
elevance to the development of AP and promising new therapeutic
pproaches.
. ROS generation in pancreatic acinar cells
Multiple sources and sites of action of ROS are likely to be rel-
vant to AP pathogenesis. For example, ROS are generated locally
ithin the acinar cell, where they can affect cell death patterns [7].
owever, they are also produced and released by circulating neu-
rophils during in the inﬂammatory response, thereby inﬂuencing
he development of pancreatic injury and systemic complications of
P [8]. In cells ROS are generated during normal respiration, a large
roportion derived from complexes I and III of the mitochondrial
lectron transport chain [10]. Increasing evidence indicates that
OS may  exert signalling roles in diverse physiological processes
11], rather than simply constituting an unwanted by-product.
owever, excessive generation of ROS has been shown to promote
amage in a variety of cell types via disruption of lipid membranes,
roteins and DNA [12]. Therefore a ﬁne balance exists between ROS
eneration and endogenous scavenging of free radicals; the out-
ome of oxidative stress is likely to reﬂect the extent and severity
f the insult that is applied to the pancreas.
Our group has demonstrated that the bile acid taurolitho-
holic acid sulphate (TLCS) induces ROS generation in human
nd murine pancreatic acinar cells, measured with confocal
icroscopy using the ﬂuorescent probe CM-DCFDA (Fig. 1
) [7]. This elevation of ROS was inhibited by the antioxidant N-
cetylcysteine and use of co-localisation analysis with MitoSOX
nd Mitotracker indicated that generation occurred within the
itochondria (Fig. 1b). Bile acids have been shown to cause sus-
ained elevations of [Ca2+]c in pancreatic acinar cells [13,14] and
he ROS response to TLCS was Ca2+-dependent, consistent with
 rise of mitochondrial Ca2+ detected using Rhod-2 [7]. Previ-
usly the importance of ROS generation in determining cell fate
ad been demonstrated in pancreatic acinar cells; the oxidant
enadione induced a rise of ROS that promoted apoptotic cell
eath [15]. Pharmacological manipulation of cellular ROS levels,
y inhibiting menadione-induced rises with the general antioxi-
ant N-acetylcysteine (NAC) or potentiating the effect by blocking
 detoxifying enzyme NAD(P)H:Quinone oxidoreductase 1 (NQO1),
nhibited or potentiated the apoptotic cell death response, accord-
ngly. Furthermore, in the same study similar manipulations of
OS levels induced by application of the bile acid TLCS modiﬁed
cinar cell death accordingly by either promoting or inhibiting apo-
tosis. These observations suggested the potential importance of
OS to inﬂuence local pancreatic injury during AP. More recently
e have developed a novel ROS probe that is localised in cellular
embranes, thereby increasing sensitivity in the detection of free
adicals by potentially avoiding quenching effects of endogenous
ntioxidants; diverse AP precipitants, including TLCS, produced
etectable elevations of ROS in murine acinar cells [16] (Fig. 1c).
. ROS interactions with Ca2+-Signalling in exocrine
ancreasA central role for Ca2+ in the pathophysiology of AP is well
ocumented, with disruption of homeostasis in pancreatic acinar
ell considered key to development [4,17–19]. Many studies have 60 (2016) 180–189
indicated the importance of inositol trisphosphate (IP3) [13,14,20]
and ryanodine [21,22] stimulated Ca2+ release channels on internal
stores to pancreatic injury induced by AP precipitants. Sustained
elevations of [Ca2+]c in response to cholecystokinin hyperstimula-
tion [4] bile salts [13,14], alcohol and its non-oxidative metabolites
(fatty acid ethyl esters, FAEEs and fatty acids) [25–27] induce
features of AP damage in acinar cells, including premature Ca2+-
dependent activation of zymogen granules, vacuole formation and
cell death [3,4] . Emerging evidence also points to the pathophysio-
logical importance of Ca2+ signalling in pancreatic ductal epithelial
cells in AP, which has recently been reviewed [26].
3.1. Ca2+ release channels
Control of cytosolic Ca2+ levels within discrete microdomains
is crucial to physiological function, requiring a ﬁne coordination
of Ca2+ release, entry and exit mechanisms [27]. The intracellular
redox status may  affect many fundamental aspects of Ca2+ sig-
nalling in the acinar cell. For example, a sensitisation of Ca2+-release
channels by exogenously applied oxidants can induce cytosolic
oscillations in the absence of physiological stimulation [28,29];
such an action may assist maintenance of IP3R-dependent Ca2+
oscillations that promote exocrine secretion [30]. IP3Rs and RyRs,
intracellular calcium release channels present on the endoplasmic
reticulum (ER) and acidic stores, possess ROS-sensitive reactive
cysteine residues [31–33], however, their modulation by oxidative
stress is complex. For example, ROS have been reported to sensi-
tize IP3-mediated activation of the IP3R but also to inhibit channel
function [34,35]. ROS-induced oxidation of thiol groups, present on
IP3Rs and RyRs, is considered excitatory since it inhibits calmod-
ulin binding to the ion channel thereby relieving an inhibitory
mechanism [36–38]. Recently, cell-permeable calmodulin activa-
tors have been shown to stimulate a protective effect of calmodulin
by inhibiting excessive Ca2+release from the internal stores through
IP3Rs and RyRs [39]. Thus increased excitation of IP3Rs and RyRs by
localised oxidative stress could deregulate Ca2+release; such mod-
ulation may  have important consequences for development of AP,
since both channels have been implicated in mediating pathologi-
cal changes in experimental AP models [21,40]. The importance of
IP3R subtypes to acinar cell physiology was  demonstrated using a
knockout mouse model; whereas individual subtype 2 and 3 IP3R
knockout minimally affected Ca2+ signals and amylase secretion
induced by ACh and CCK, dual knockout abolished such responses
[41]. The IP3R was implicated in mediating Ca2+ signals induced
by toxic non-oxidative alcohol metabolites [24] and subsequent
work using knockout mice showed that subtypes 2 and 3 were
necessary for Ca2+release, trypsinogen activation and acinar cell
death [18]. Recently, the potential for AP therapy by inhibition of
IP3R-mediated Ca2+release was demonstrated [40]. Caffeine and
its dimethylxanthine metabolites inhibited IP3R-mediated, sus-
tained cytosolic Ca2+ elevations, loss of mitochondrial membrane
potential and necrotic cell death pathway activation in pancreatic
acinar cells (Fig. 2a). Importantly, caffeine and its dimethylxan-
thine metabolites also ameliorated pancreatic injury in multiple
experimental AP models through IP3R-mediated signalling inhi-
bition. Interestingly, coffee drinking was previously found to be
associated with a reduced risk of alcoholic AP [42]. Current evi-
dence supports inhibition of Ca2+ overload and its consequences
as a potential approach for AP therapy, and methylxanthine-based
structures would appear suitable starting points for drug discovery
and development.3.2. Ca2+ entry mechanisms
Of particular recent interest in the ﬁeld has been an improved
understanding of important Ca2+ entry mechanisms present in
D.N. Criddle / Cell Calcium 60 (2016) 180–189 183
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levations induced by (i) IP3 uncaging, (ii) TLCS application, and (iii) resultant nec
GlaxoSmithKline) and CM 128 (CalciMedica), on sustained [Ca2+]c elevations induc
ancreatic acinar cells, that mediate sustained pathophysiological
levations of [Ca2+]c causing mitochondrial injury and cell death.
everal ion channels have been implicated in pancreatic acinar
ell pathophysiology. For example, TRPC3 channels have previously
een shown to partially mediate sustained [Ca2+]c rises triggered
y bile acids and FAEEs in pancreatic acinar cells and to amelio-
ate experimental AP [43]. Recent evidence has demonstrated a
ole for the STIM1-Orai complex as the principal Ca2+ entry chan-murine pancreatic acinar cells. A) Effects of the IP3R blocker caffeine to inhibit Ca2+
f mouse pancreatic acinar cells [40]. B) Effects of new Orai1 blockers, GSK-7975A
 TLCS and necrosis of isolated human pancreatic acinar cells [19].
nel in this cell type [19,44,45]. The STIM1 protein is sensitive to
the Ca2+ content of the ER store; when stores are depleted this
protein clusters at the ER-plasma membrane junction where it
interacts with Orai1 subunits to form a functional complex that
allows entry of Ca2+ into the cell [46–48]. Pharmacological inhibi-
tion of Orai1 channels reduced pathological Ca2+ entry into murine
pancreatic acinar cells, necrotic cell death and trypsin activation
induced by alcohol non-oxidative metabolites, suggesting the ther-
184 D.N. Criddle / Cell Calcium 60 (2016) 180–189
Fig. 3. Cell death patterns in human and murine pancreatic acinar cells. A) (i) Inhibition of bile acid TLCS-induced ROS generation by N-acetylcysteine (NAC) reduced apoptotic
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yclophilin D (PPIF−/−) or pharmacological inhibition of MPTP formation (with cyclo
as  unaffected [73].
peutic potential of Ca2+ release-activated Ca2+ channel blockade to
meliorate AP [45]. Subsequently, it was shown that inhibitors of
rai1 prevented Ca2+-dependent injury of human pancreatic aci-
ar cells (Fig. 2b) and experimental AP in three mouse models
19]. Importantly, the Orai1 blockers, GSK-7975A and CM 128, were
pplied as treatments i.e. post-induction of AP, emphasizing the
ranslational potential for this novel therapeutic approach; CM 128
ill shortly enter into Phase One clinical trials for AP. The Orai1
rotein possesses an externally located cysteine residue which ren-
ers it sensitive to modulation by ROS. Sensitization of the Ca2+
ntry process by ROS may  therefore have implications for pancre-
tic acinar cell damage, however, this has not been evaluated so far.
ifferences between Orai channel subtypes have been reported;
n contrast to Orai1, Orai3 is insensitive to oxidative stress since
t lacks the external cysteine residue [49]. This may  be of impor-ng enzyme NQO1 with DMN  produced the converse effect [7]. B) Genetic deletion of
 A (CYA) and Debio-025) reduced pancreatic acinar cell necrosis, whereas apoptosis
tance to the immune response in AP since T-lymphocytes become
increasingly resistant to ROS after differentiation into effector cells,
a feature linked to increased Orai3 expression. Under oxidizing
conditions of the inﬂamed pancreas such a modiﬁcation might
facilitate proliferation, differentiation and cytokine production.
Furthermore, a Ca2+-redox feedback loop has recently been shown
to control human monocyte immune responses [50]. Exposure to
bacterial peptides or infection with pathogens promoted Orai/STIM
mediated Ca2+ entry, the magnitude of which determined the rate
of ROS production via NADPH oxidase 2 (NOX2). This study indi-
cated that monocytes can optimize their ROS response by altering
the Orai1/Orai3 ratio, thereby ﬁne-tuning negative feedback from
NOX2 to the Orai/STIM channel.
lcium 60 (2016) 180–189 185
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Fig. 4. A hypothetical model illustrating the outcome of increasing stress on
pancreatic acinar cell fate. Low levels of stress induced by precipitants of acute
pancreatitis (AP), including bile acids, non-oxidative ethanol metabolites (fatty acid
ethyl esters: FAEEs) and cholecystokinin (CCK) hyperstimulation, induce sustained
[Ca2+]c elevations that raise mitochondrial Ca2+. Ca2+-dependent ROS generation in
the  mitochondria preferentially promotes apoptotic cell death, which may consti-
tute a local protective mechanism whereby necrosis is avoided. However, as the
level and/or duration of stress increases a shift from apoptotic to necrotic cell death
ensues. Formation of the MPTP causes mitochondrial depolarisation and a fall of ATP
with resultant necrotic cell death. Strategies that reduce [Ca2+] overload or protectD.N. Criddle / Cell Ca
.3. Ca2+ extrusion/uptake mechanisms
The pancreatic acinar cell is critically dependent on the regular
roduction and supply of intracellular ATP for [Ca2+]c homeostasis.
his situation contrasts with excitable cell types, such as those of
ardiac and neuronal tissues, which possess a Na+/Ca2+ exchanger
hat can decrease [Ca2+]c elevations; this appears to be absent or
on-functional in pancreatic acinar cells. As such, the integrity
f mitochondria in pancreatic acinar cells is paramount to nor-
al  functioning of the exocrine unit; disruption of this organelle
ia formation of the mitochondrial permeability transition pore
MPTP) has strongly been implicated in the development of AP
51,73]. The acinar cell has two ATP-dependent [Ca2+]c clearance
echanisms, the Sarco-Endoplasmic reticulum (SERCA) and Plas-
alemmal (PMCA) Ca2+-ATPases. Both pumps are modulated by
xidative stress, since they contain ROS-sensitive cysteine residues
52]. In pancreatic acinar cells oscillatory [Ca2+]c responses to CCK
r ACh were altered in a concentration-dependent manner by
2O2; sustained, global, [Ca2+]c responses were promoted by this
adical [53]. Since, mitochondrial impairment and consequent ATP
epletion in response to H2O2 was correlated with a fall in PMCA
ctivity [54], such transformation of [Ca2+]c patterns might, at least
n part, be mediated via decreased PMCA-mediated [Ca2+] c clear-
nce from the cytosol. However, the effects of ROS are likely to
e highly concentration-dependent. Mild oxidative conditions can
ositively inﬂuence SERCA pump activity via oxidation of a spe-
iﬁc cysteine residue (Cys674) [55], whereas prolonged exposure to
xidative stress may  cause irreversible SERCA inhibition and over-
oad of [Ca2+] c via sulphonylation of this amino-acid together with
xidation of other residues [55–57]. Thus the extent and duration of
xidative stress is likely to determine outcome. Recently an impor-
ant role of Bcl-2 in modulating PMCA activity and inﬂuencing cell
eath was demonstrated [58]. Ca2+ extrusion from AR42J cells was
iminished by the overexpression of Bcl-2 and augmented by Bcl-2
ilencing. Interestingly, a loss of Bcl-2 enhanced apoptosis induced
y oxidative stress and dramatically decreased necrosis.
. Involvement of ROS in AP: experimental models
Oxidative stress occurs in the pathogenesis of many diseases,
ncluding AP [59,60]; elevated levels of free radicals and/or their by-
roducts, together with a reduction of antioxidant defences, have
een reported in both animal experimental AP models and patient
tudies (recently reviewed; [9]). Several early clinical investigations
uggested a prominent role for oxidative stress in AP development
61–64]. For example, oxidative stress in patients was  detected
arly in the course of AP and persisted longer than clinical man-
festations of the disease [61]. Such changes were linked to disease
everity; signiﬁcantly elevated ROS markers, together with reduced
ntioxidant levels, were detected in AP patients that were different
etween mild and severe patient groups.
Preclinical studies have also demonstrated that oxidative stress
s present in experimental AP. For example, the extent of pancreatic
njury in experimental caerulein-induced AP (CER-AP) correlated
ith reduced glutathione (GSH) depletion [65]. Subsequently it
as shown that probiotics, which stimulated the biosynthesis of
SH, reduced oxidative stress in this model [66]. However, such
 manipulation did not correlate with a positive outcome in the
linic; administration of probiotics to severe AP patients early after
isease onset more than doubled the relative risk of mortality
67], although the study design has been questioned [68]. In the
at CER-AP model administration of SOD and catalase post-insult
meliorated ultrastructural and biochemical damage, however,
re-treatment was unprotective [69]. Furthermore, a comparison
f agents applied to reduce oxidative stress in CER-AP, and in a morec
mitochondria by preventing MPTP formation are likely to be promising therapeutic
avenues for the treatment of AP.
severe choline-deﬁcient ethionine-supplemented diet AP model,
only detected a decrease in pancreatic oedema; the study con-
cluded that ROS might therefore play a role in development of
pancreatic oedema but appeared unlikely to be instrumental in the
development of acinar cell damage [70].
Although CER-AP is a convenient and reliable model of AP [71],
other approaches may  have more direct clinical relevance. For
example, the ductal infusion of bile acids, such as taurolithocholic
acid sulphate (TLCS), caused a more severe form of experimental
AP [72,73]. In rats, bile acid-induced AP oxidative stress has been
shown, including elevated MDA  levels in pancreas and reduction of
SOD activity [74]. In accord, local and systemic oxidative stress was
also recently demonstrated in taurocholate-induced AP in obese
rats [75]. Interestingly, although a signiﬁcant protection of acinar
cell damage and inﬂammation was observed by the scavenging of
ROS in this model, such an intervention did not alter GSH, mal-
ondialdehyde (MDA), amylase or lipase levels or affect pancreatic
oedema [76]. Furthermore, and perhaps of fundamental impor-
tance to the question of the role of ROS in AP, generation of ROS
alone did not induce biochemical or morphological changes typical
of AP, strongly implying that factors other than ROS are involved in
triggering AP damage in vivo.
In accord, we  have recently evaluated the effects of a
mitochondrial-targeted antioxidant Mitoquinone (MitoQ) in bile
acid- and caerulein-induced AP in mice. MitoQ has been shown
to be protective in diverse pathologies associated with oxida-
tive stress, including diabetes [77], cardiac ischaemia-reperfusion
injury [78] and sepsis [79]. In the severe TLCS-AP model, however,
no beneﬁcial effects of MitoQ treatment were detected, although
MitoQ was  effective in abolishing H2O2-induced increases of ROS
in isolated pancreatic acinar cells [80]. Some limited protection was
observed in the milder CER-AP model, however, such effects were
shared by the non-antioxidant analogue control decylTPP, suggest-
ing non-speciﬁc effects of MitoQ. Furthermore, certain parameters
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Fig. 5. Schematic illustrating translational approaches for treatment of acute pan-
creatitis (AP). Precipitants of AP deplete internal Ca2+ stores in pancreatic acinar
cells which elicits store-operated Ca2+ entry (SOCE) and consequent cytosolic Ca2+
overload. Mitochondrial dysfunction ensues, via the formation of the mitochondrial
permeability transition pore (MPTP), which depletes cellular ATP, the pivotal trigger
for  necrotic cell death. Furthermore, ATP rundown inhibits Ca2+ clearance from the
cytosol via the plasmalemmal and sarco-endoplasmic Ca2+-ATPase pumps (PMCA
and SERCA) culminating in a vicious cycle that perpetuates Ca2+ overload and acinar
cell death. Recent evidence has demonstrated that prevention of cytosolic Ca2+ over-
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coad or direct inhibition of MPTP formation using speciﬁc pharmacological agents
rotects against acinar cell necrosis and ameliorates experimental AP (see main text
or  further details).
.e. interleukin-6 and lung MPO  increases in CER-AP were exacer-
ated by MitoQ indicating complexity of antioxidant effects. Our
ecent results contrast with prior evidence suggesting a protec-
ive action of antioxidants in the bile-acid-induced AP model [81].
he general antioxidant N-acetylcysteine (NAC), which prevents
xidant-induced ROS increases in pancreatic acinar cells [7,15],
meliorated taurocholate-induced AP in rats. However, it should be
oted that in this study NAC was administered prior to induction of
P, which does not accurately reﬂect the clinical situation in which
isease has already undergone signiﬁcant progression on patient
dmission. Consistent with this, a study in mice clearly showed
hat only prophylactic treatment with NAC i.e. before AP induction,
as successful in limiting the severity of experimental AP, whereas
ntioxidant therapy was ineffective when given post-insult [82].
. Involvement of ROS in AP: a translational gap
Whilst the importance of [Ca2+]c overload to development of
cinar cell damage has been ﬁrmly established [4,18,83], and
otential treatment strategies for protection via inhibition of Ca2+
elease [40] and entry [19,45] demonstrated in preclinical in vivo
odels, the translational value of ROS inhibition with antioxi-
ants has appeared less convincing [9]. Clinical evaluations of
ntioxidant therapy in AP patients have produced variable out-
omes, despite encouraging results from some early studies. For 60 (2016) 180–189
example, a combination of selenium, vitamins C and E, -carotene
and methionine improved AP in a small patient study [84], whilst
selenium alone reduced AP mortality in a non-randomised trial
[85,86]; no severe AP patients, however, were examined in these
investigations. Additionally, treatment of patients with an intra-
venous high dose vitamin C, which decreased oxidative stress
markers in blood, caused a faster recovery from AP symptoms com-
pared to low dose vitamin C and healthy control patients, although
the fate of the severe AP patients was  incompletely documented
[87]. Time-dependent increases in ROS have been demonstrated in
a preclinical study in rats in response to ductal ligation [88] and
some beneﬁt of antioxidant therapy in post-ERCP AP was  reported
in a prospective, double-blinded, placebo-controlled trial [89]; high
dose allopurinol, applied prior to the surgical procedure, reduced
AP incidence. Such a protective effect is therefore consistent with
the efﬁcacy of antioxidants in preclinical experimental AP models
when administered as pre-treatments.
However, other clinical trial outcomes have been less positive.
For example, a prospective randomised, controlled study failed to
demonstrate a reduction of hospital stay or complication rates
in AP patients, although antioxidant treatment was effective in
decreasing oxidative stress [90]. Similarly, combined antioxidant
therapy did not reduce in-hospital mortality in patients with pre-
dicted severe AP, despite a signiﬁcant restoration of vitamin C
and selenium levels towards normal following treatment [91].
More recently, a carefully controlled randomised, double-blind
placebo trial of combined antioxidant therapy in severe AP patients
detected no difference in organ dysfunction or patient outcome
[92]. In this study, serum antioxidant levels were elevated whilst
markers of oxidative stress fell during treatment. Importantly,
this study revealed a trend towards more deleterious outcome in
patients given antioxidant therapy. A subsequent study showed no
signiﬁcant difference in organ dysfunction and length of hospital
stay associated with combined antioxidant treatment in severe AP
patients, despite restoration of redox balance [93].
6. Current status?
How might the variable effects of antioxidants in the clinic be
explained? It is important to consider that ROS are generated in
multiple places during AP and a blanket inhibition with general
antioxidants may  inﬂuence manifold processes. In addition to local
generation of ROS within the acinar cell, there is likely to be a
signiﬁcant involvement of ROS produced during the inﬂamma-
tory response; both activation and proliferation of immune cells
are promoted by ROS [94–96] and ROS production is enhanced in
neutrophils obtained from AP patients [97]. Since recruitment of
immune cells to the pancreas occurs during the course of AP [98],
generation of ROS via neutrophil NADPH oxidase may exert a signif-
icant inﬂuence on AP damage; in accord, depletion of neutrophils
was protective in experimental AP [99]. Furthermore, interactions
between oxidative stress and pro-inﬂammatory cytokines via MAP
kinases and protein phosphatases may  potentiate the inﬂammatory
response and worsen tissue injury in AP [100,101]. In this context
application of antioxidants to speciﬁcally target the inﬂammatory
response in AP may  be beneﬁcial. However, the antioxidant MitoQ
exerted biphasic effects on ROS production in polymorphonu-
clear leukocytes, generated via activation of NADPH oxidase [80].
Thus, phorbol ester-induced acute ROS production was inhibited,
whereas a later phase was potentiated, highlighting complexity
of antioxidant action. Current evidence suggests that the contri-
bution of ROS in AP via NADPH oxidase is likely to be restricted
to production from inﬂammatory cells, since this enzyme was not
detectable in primary pancreatic acinar cells [99], while bile acid- or
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enadione-induced ROS rises were not altered by pharmacological
nhibition using diphenyliodonium [7,15].
Perhaps most importantly in relation to the observed negative
utcomes of antioxidants in clinical trials is their action to inhibit
OS-induced apoptotic cell death [7,15]. Inhibition of bile acid-
nduced ROS generation shifted the balance of pancreatic acinar
ell death from apoptosis toward necrosis (Fig. 3a) [7]. Activation
f the apoptotic cell death pathway is considered less damaging
han necrosis, since this allows cell debris to be effectively removed
y macrophages [102]; necrosis can instigate an inﬂammatory
esponse in tissues surrounding the pancreas [5,103]. Inhibitory
ctions of antioxidants on ROS may  therefore prejudice an endoge-
ous protective mechanism to cope with cells undergoing stress.
n agreement, a reduction of apoptosis via inhibition of caspase
ctivity has been shown to produce a more severe necrotizing
ancreatitis [104–106]. In pancreatic acinar cells necrosis ensues
hen ATP production is compromised due to Ca2+-dependent mito-
hondrial dysfunction, mediated by MPTP opening [51,73,107].
upplementation of intracellular ATP to acinar cells stimulated by
almitoleic acid or bile acid was protective in acinar [7,24] and duc-
al [108] cells. It has been proposed that ATP depletion is the trigger
or necrotic cell death [109] and a gradation of cell death from
poptosis to necrosis may  exist that is dependent on the extent
nd severity of the insult (Fig. 4). In a recent study, we showed
hat pharmacological inhibition or genetic deletion of cyclophilin
 (PPIF−/−), which modulates the MPTP, reduced necrotic, but not
poptotic, cell death in response to AP precipitants (Fig. 3b). Fur-
hermore, pharmacological inhibition of cyclophilin D ameliorated
P in a variety of in vivo experimental models, including a sig-
iﬁcant reduction of pancreatic necrosis, suggesting the potential
or therapeutic intervention in the clinic [73]. These results are
onsistent with earlier work demonstrating that the absence of
yclophilin D markedly protected mice from necrosis, whereas nor-
al  apoptotic cell death responses were retained [114]. Recent
vidence shows that oxidative stress can modulate cyclophilin D
ctivity, consistent with a model of ROS-sensitized Ca2+-dependent
PTP induction [111,112] and this protein may  act as a general
edox sensor within the mitochondria [113]. However, the actions
f oxidative stress on MPTP formation in exocrine pancreas have yet
o be elucidated. Interestingly, differences between the properties
f mitochondria in different cell types have been reported [114];
odulation of MPTP formation may  thus vary between tissues and
urther investigation is warranted.
. Conclusions: therapeutic avenues?
Ca2+ homeostasis is paramount for normal physiological func-
ioning of the exocrine pancreas; this is achieved by a ﬁne balance
etween Ca2+ release from internal stores, Ca2+ entry and extrusion
echanisms. Disruption results in Ca2+ overload of the acinar cell
hat causes mitochondrial dysfunction, via formation of the MPTP,
oss of ATP production and consequent necrosis. Oxidative stress, at
ow levels, preferentially promotes apoptosis which may  be beneﬁ-
ial in AP by avoiding necrosis that can trigger severe inﬂammation;
pplication of antioxidants may  therefore prejudice an endogenous
rotective mechanism and this approach has proven unsuitable as
P therapy in the clinic. In contrast, recent evidence has indicated
hat prevention of Ca2+-dependent mitochondrial damage appears
 promising strategy for AP therapy [73,115]. Multiple approaches
ave been suggested from preclinical ﬁndings (Fig. 5); 1) inhibition
f Ca2+ release by IP3R blockade, 2) inhibition of Ca2+ entry through
rai1 blockade and 3) prevention of MPTP formation. Clinical tri-
ls of selective drugs, such as CM 128, which prevent mitochondrial
ysfunction induced by Ca2+ overload of pancreatic acinar cells, are 60 (2016) 180–189 187
imminent and will hopefully provide signiﬁcant patient beneﬁt for
a disease that currently lacks speciﬁc therapy.
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